Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus

Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

6,425 public trials 530 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus trial results

Completed

Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

NCT02662569

Conditions
Diabetes Mellitus, Diabetes, Hyperlipidemia, Mixed Dyslipidemia, Dyslipidemias, +6 more
Locations
  • Research Site Miami, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Iowa City, Iowa, United States
View all 110 locations
View Trial Details
Completed

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

NCT02229383

Conditions
Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntsville, Alabama, United States
  • Research Site Muscle Shoals, Alabama, United States
  • Research Site Tempe, Arizona, United States
View all 123 locations
View Trial Details
Completed

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

NCT02207374

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Akita-shi, Akita, Japan
  • Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan
  • Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan
  • Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan
View all 43 locations
View Trial Details
Completed

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes

NCT01392573

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
View all 86 locations
View Trial Details

Related conditions